The Biobanque québécoise de la COVID-19 (BQC19) and the Réseau québécois COVID-Pandémie (RQCP) are pleased to announce the implementation of the access process for preliminary genotyping data from the BQC19 collection. The available data include twelve baseline variables and genome-wide genotyping on just over 500 samples, divided between SARS-CoV-2 positive participants and case controls. For more details, please see the section "DATA ACCESS" for the access request process and the "RESEARCH" section for information on the "STUDY DESIGN". Data access requests will be accepted from August 17, 2020.

Research is needed to better understand how and why the SARS CoV-2 coronavirus infection causes atypical pneumonia called COVID-19 in some people.

Research is also essential to:

• Develop treatments and vaccines
• Identify people at risk and take appropriate measures to protect them
• Help the government take social measures to control the spread of the infection
• Predict and better prepare for possible future pandemics

To achieve this goal, collecting high quality biological samples and medical data from patients infected with COVID-19 is absolutely essential.
Accordingly, the « Fonds de recherche du Québec – Santé (FRQS) » and Genome Quebec have mandated a group of researchers from the province to establish the Biobanque québécoise de la COVID-19 (BQC).
The BQC provides the infrastructure required to accomplish this mission of sharing and supporting provincial, national and international research efforts related to the prevention, treatment, epidemiological and population management of COVID-19.

For more information, contact us